Glenmark gets nod from Russian Ministry of Healthcare for Momate Rhino nasal spray

25 Apr 2019 Evaluate

Glenmark Pharmaceuticals has received approval from the Ministry of Healthcare, Russia to market Momate Rhino (Mometasone Furoate 50 mcg) metered nasal spray as an over?the?counter (OTC) product for the treatment of seasonal and perennial allergic rhinitis in patients above 18 years of age. 

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1948.45 -17.60 (-0.90%)
17-Dec-2025 15:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.30
Dr. Reddys Lab 1271.95
Cipla 1496.75
Zydus Lifesciences 917.00
Lupin 2113.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×